The global mRNA Vaccines for Animals market was valued at US$ 144 million in 2025 and is anticipated to reach US$ 3896 million by 2032, at a CAGR of 61.1% from 2026 to 2032.

mRNA Vaccines for Animals Market

mRNA vaccines for animals are a type of veterinary vaccine that use messenger RNA (mRNA) technology to stimulate an immune response against specific pathogens in livestock, pets, and other animals. These vaccines work by delivering synthetic mRNA encoding viral or bacterial antigens into the animal’s cells, prompting the immune system to recognize and fight the targeted disease. Compared to traditional vaccines, mRNA vaccines offer faster development timelines, improved efficacy, and the ability to rapidly adapt to emerging animal diseases. They are being explored for various applications, including livestock diseases (such as foot-and-mouth disease), zoonotic infections, and companion animal health.

Market Development Opportunities & Main Driving Factors

mRNA vaccines for animals, as a new generation of biological products, are reshaping the global veterinary vaccine landscape with their rapid development, high specificity, and scalability. According to annual reports from animal health companies and brokerage research, the demand for epidemic prevention in the livestock industry continues to rise, particularly against transboundary infectious diseases and major animal epidemics, which accelerates investment in novel vaccines. The proven success of mRNA technology in human COVID-19 vaccines validates its potential in veterinary applications. Coupled with strong policy support for food safety, livestock modernization, and public health, the market expansion potential for animal mRNA vaccines is significant.

Market Challenges, Risks, & Restraints

Despite promising prospects, animal mRNA vaccines face multiple challenges. Their storage, transportation, and mass production require stringent cold chain and advanced equipment, leading to higher costs compared to traditional vaccines. Regulatory frameworks remain immature, with varying standards for registration and safety validation across regions, adding uncertainty to commercialization. Additionally, the industry is dominated by multinational animal health giants with strong technological and financial advantages, creating barriers for smaller firms facing fierce competition and potential technological hurdles.

Downstream Demand Trends

As livestock farming becomes increasingly large-scale and intensive, and as consumer awareness of food safety and animal health grows, demand for safe and effective novel vaccines continues to rise. In particular, poultry, swine, and companion animal sectors exhibit strong demand for rapid-response vaccines against emerging diseases. Growing government investment in animal disease prevention and farmers’ need to reduce losses and improve efficiency will further drive adoption. In the long term, animal mRNA vaccines are poised to become a critical technology supporting livestock stability and food supply security.

This report delivers a comprehensive overview of the global mRNA Vaccines for Animals market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding mRNA Vaccines for Animals. The mRNA Vaccines for Animals market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global mRNA Vaccines for Animals market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist mRNA Vaccines for Animals manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of mRNA Vaccines for Animals Market Report

Report Metric	Details
Report Name	mRNA Vaccines for Animals Market
Accounted market size in 2025	US$ 144 million
Forecasted market size in 2032	US$ 3896 million
CAGR	61.1%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	Non-replicating mRNA vaccines Self-replicating mRNA vaccines
Segment by Application	Pigs Poultry Companion Animals Ruminants
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Ceva Animal Health, Merck Animal Health, Areterna, Bayer, BioNTech, Genvax Technologies, BioVenic, Moderna, Ruipu Biotechnology, Jinyu Bio-technology, Shanghai Shen Lian Biomedical, Suzhou Kerui Meide Biomedical Technology, Shanghai Rnacure Biopharma
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for mRNA Vaccines for Animals companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is mRNA Vaccines for Animals Market growing?

Ans: The mRNA Vaccines for Animals Market witnessing a CAGR of 61.1% during the forecast period 2026-2032.

What is the mRNA Vaccines for Animals Market size in 2032?

Ans: The mRNA Vaccines for Animals Market size in 2032 will be US$ 3896 million.

Who are the main players in the mRNA Vaccines for Animals Market report?

Ans: The main players in the mRNA Vaccines for Animals Market are Ceva Animal Health, Merck Animal Health, Areterna, Bayer, BioNTech, Genvax Technologies, BioVenic, Moderna, Ruipu Biotechnology, Jinyu Bio-technology, Shanghai Shen Lian Biomedical, Suzhou Kerui Meide Biomedical Technology, Shanghai Rnacure Biopharma

What are the Application segmentation covered in the mRNA Vaccines for Animals Market report?

Ans: The Applications covered in the mRNA Vaccines for Animals Market report are Pigs, Poultry, Companion Animals, Ruminants

What are the Type segmentation covered in the mRNA Vaccines for Animals Market report?

Ans: The Types covered in the mRNA Vaccines for Animals Market report are Non-replicating mRNA vaccines, Self-replicating mRNA vaccines

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global mRNA Vaccines for Animals Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 Non-replicating mRNA vaccines

1.2.3 Self-replicating mRNA vaccines

1.3 Market by Application

1.3.1 Global mRNA Vaccines for Animals Market Growth by Application: 2021 vs 2025 vs 2032

1.3.2 Pigs

1.3.3 Poultry

1.3.4 Companion Animals

1.3.5 Ruminants

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global mRNA Vaccines for Animals Market Perspective (2021–2032)

2.2 Global mRNA Vaccines for Animals Growth Trends by Region

2.2.1 Global mRNA Vaccines for Animals Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 mRNA Vaccines for Animals Historic Market Size by Region (2021–2026)

2.2.3 mRNA Vaccines for Animals Forecasted Market Size by Region (2027–2032)

2.3 mRNA Vaccines for Animals Market Dynamics

2.3.1 mRNA Vaccines for Animals Industry Trends

2.3.2 mRNA Vaccines for Animals Market Drivers

2.3.3 mRNA Vaccines for Animals Market Challenges

2.3.4 mRNA Vaccines for Animals Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top mRNA Vaccines for Animals Players by Revenue

3.1.1 Global Top mRNA Vaccines for Animals Players by Revenue (2021–2026)

3.1.2 Global mRNA Vaccines for Animals Revenue Market Share by Players (2021–2026)

3.2 Global Top mRNA Vaccines for Animals Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by mRNA Vaccines for Animals Revenue

3.4 Global mRNA Vaccines for Animals Market Concentration Ratio

3.4.1 Global mRNA Vaccines for Animals Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by mRNA Vaccines for Animals Revenue in 2025

3.5 Global Key Players of mRNA Vaccines for Animals Head Offices and Areas Served

3.6 Global Key Players of mRNA Vaccines for Animals, Products and Applications

3.7 Global Key Players of mRNA Vaccines for Animals, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 mRNA Vaccines for Animals Breakdown Data by Type

4.1 Global mRNA Vaccines for Animals Historic Market Size by Type (2021–2026)

4.2 Global mRNA Vaccines for Animals Forecasted Market Size by Type (2027–2032)

5 mRNA Vaccines for Animals Breakdown Data by Application

5.1 Global mRNA Vaccines for Animals Historic Market Size by Application (2021–2026)

5.2 Global mRNA Vaccines for Animals Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America mRNA Vaccines for Animals Market Size (2021–2032)

6.2 North America mRNA Vaccines for Animals Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America mRNA Vaccines for Animals Market Size by Country (2021–2026)

6.4 North America mRNA Vaccines for Animals Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe mRNA Vaccines for Animals Market Size (2021–2032)

7.2 Europe mRNA Vaccines for Animals Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe mRNA Vaccines for Animals Market Size by Country (2021–2026)

7.4 Europe mRNA Vaccines for Animals Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific mRNA Vaccines for Animals Market Size (2021–2032)

8.2 Asia-Pacific mRNA Vaccines for Animals Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific mRNA Vaccines for Animals Market Size by Region (2021–2026)

8.4 Asia-Pacific mRNA Vaccines for Animals Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America mRNA Vaccines for Animals Market Size (2021–2032)

9.2 Latin America mRNA Vaccines for Animals Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America mRNA Vaccines for Animals Market Size by Country (2021–2026)

9.4 Latin America mRNA Vaccines for Animals Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa mRNA Vaccines for Animals Market Size (2021–2032)

10.2 Middle East & Africa mRNA Vaccines for Animals Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa mRNA Vaccines for Animals Market Size by Country (2021–2026)

10.4 Middle East & Africa mRNA Vaccines for Animals Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Ceva Animal Health

11.1.1 Ceva Animal Health Company Details

11.1.2 Ceva Animal Health Business Overview

11.1.3 Ceva Animal Health mRNA Vaccines for Animals Introduction

11.1.4 Ceva Animal Health Revenue in mRNA Vaccines for Animals Business (2021–2026)

11.1.5 Ceva Animal Health Recent Development

11.2 Merck Animal Health

11.2.1 Merck Animal Health Company Details

11.2.2 Merck Animal Health Business Overview

11.2.3 Merck Animal Health mRNA Vaccines for Animals Introduction

11.2.4 Merck Animal Health Revenue in mRNA Vaccines for Animals Business (2021–2026)

11.2.5 Merck Animal Health Recent Development

11.3 Areterna

11.3.1 Areterna Company Details

11.3.2 Areterna Business Overview

11.3.3 Areterna mRNA Vaccines for Animals Introduction

11.3.4 Areterna Revenue in mRNA Vaccines for Animals Business (2021–2026)

11.3.5 Areterna Recent Development

11.4 Bayer

11.4.1 Bayer Company Details

11.4.2 Bayer Business Overview

11.4.3 Bayer mRNA Vaccines for Animals Introduction

11.4.4 Bayer Revenue in mRNA Vaccines for Animals Business (2021–2026)

11.4.5 Bayer Recent Development

11.5 BioNTech

11.5.1 BioNTech Company Details

11.5.2 BioNTech Business Overview

11.5.3 BioNTech mRNA Vaccines for Animals Introduction

11.5.4 BioNTech Revenue in mRNA Vaccines for Animals Business (2021–2026)

11.5.5 BioNTech Recent Development

11.6 Genvax Technologies

11.6.1 Genvax Technologies Company Details

11.6.2 Genvax Technologies Business Overview

11.6.3 Genvax Technologies mRNA Vaccines for Animals Introduction

11.6.4 Genvax Technologies Revenue in mRNA Vaccines for Animals Business (2021–2026)

11.6.5 Genvax Technologies Recent Development

11.7 BioVenic

11.7.1 BioVenic Company Details

11.7.2 BioVenic Business Overview

11.7.3 BioVenic mRNA Vaccines for Animals Introduction

11.7.4 BioVenic Revenue in mRNA Vaccines for Animals Business (2021–2026)

11.7.5 BioVenic Recent Development

11.8 Moderna

11.8.1 Moderna Company Details

11.8.2 Moderna Business Overview

11.8.3 Moderna mRNA Vaccines for Animals Introduction

11.8.4 Moderna Revenue in mRNA Vaccines for Animals Business (2021–2026)

11.8.5 Moderna Recent Development

11.9 Ruipu Biotechnology

11.9.1 Ruipu Biotechnology Company Details

11.9.2 Ruipu Biotechnology Business Overview

11.9.3 Ruipu Biotechnology mRNA Vaccines for Animals Introduction

11.9.4 Ruipu Biotechnology Revenue in mRNA Vaccines for Animals Business (2021–2026)

11.9.5 Ruipu Biotechnology Recent Development

11.10 Jinyu Bio-technology

11.10.1 Jinyu Bio-technology Company Details

11.10.2 Jinyu Bio-technology Business Overview

11.10.3 Jinyu Bio-technology mRNA Vaccines for Animals Introduction

11.10.4 Jinyu Bio-technology Revenue in mRNA Vaccines for Animals Business (2021–2026)

11.10.5 Jinyu Bio-technology Recent Development

11.11 Shanghai Shen Lian Biomedical

11.11.1 Shanghai Shen Lian Biomedical Company Details

11.11.2 Shanghai Shen Lian Biomedical Business Overview

11.11.3 Shanghai Shen Lian Biomedical mRNA Vaccines for Animals Introduction

11.11.4 Shanghai Shen Lian Biomedical Revenue in mRNA Vaccines for Animals Business (2021–2026)

11.11.5 Shanghai Shen Lian Biomedical Recent Development

11.12 Suzhou Kerui Meide Biomedical Technology

11.12.1 Suzhou Kerui Meide Biomedical Technology Company Details

11.12.2 Suzhou Kerui Meide Biomedical Technology Business Overview

11.12.3 Suzhou Kerui Meide Biomedical Technology mRNA Vaccines for Animals Introduction

11.12.4 Suzhou Kerui Meide Biomedical Technology Revenue in mRNA Vaccines for Animals Business (2021–2026)

11.12.5 Suzhou Kerui Meide Biomedical Technology Recent Development

11.13 Shanghai Rnacure Biopharma

11.13.1 Shanghai Rnacure Biopharma Company Details

11.13.2 Shanghai Rnacure Biopharma Business Overview

11.13.3 Shanghai Rnacure Biopharma mRNA Vaccines for Animals Introduction

11.13.4 Shanghai Rnacure Biopharma Revenue in mRNA Vaccines for Animals Business (2021–2026)

11.13.5 Shanghai Rnacure Biopharma Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Shanghai Shen Lian Biomedical

Suzhou Kerui Meide Biomedical Technology

Shanghai Rnacure Biopharma

List of Tables

Table 1. Global mRNA Vaccines for Animals Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of Non-replicating mRNA vaccines

Table 3. Key Players of Self-replicating mRNA vaccines

Table 4. Global mRNA Vaccines for Animals Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 5. Global mRNA Vaccines for Animals Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 6. Global mRNA Vaccines for Animals Market Size by Region (US$ Million), 2021–2026

Table 7. Global mRNA Vaccines for Animals Market Share by Region (2021–2026)

Table 8. Global mRNA Vaccines for Animals Forecasted Market Size by Region (US$ Million), 2027–2032

Table 9. Global mRNA Vaccines for Animals Market Share by Region (2027–2032)

Table 10. mRNA Vaccines for Animals Market Trends

Table 11. mRNA Vaccines for Animals Market Drivers

Table 12. mRNA Vaccines for Animals Market Challenges

Table 13. mRNA Vaccines for Animals Market Restraints

Table 14. Global mRNA Vaccines for Animals Revenue by Players (US$ Million), 2021–2026

Table 15. Global mRNA Vaccines for Animals Market Share by Players (2021–2026)

Table 16. Global Top mRNA Vaccines for Animals Players by Tier (Tier 1, Tier 2, and Tier 3), based on mRNA Vaccines for Animals Revenue, 2025

Table 17. Ranking of Global Top mRNA Vaccines for Animals Companies by Revenue (US$ Million) in 2025

Table 18. Global 5 Largest Players Market Share by mRNA Vaccines for Animals Revenue (CR5 and HHI), 2021–2026

Table 19. Global Key Players of mRNA Vaccines for Animals, Headquarters and Area Served

Table 20. Global Key Players of mRNA Vaccines for Animals, Products and Applications

Table 21. Global Key Players of mRNA Vaccines for Animals, Date of General Availability (GA)

Table 22. Mergers and Acquisitions, Expansion Plans

Table 23. Global mRNA Vaccines for Animals Market Size by Type (US$ Million), 2021–2026

Table 24. Global mRNA Vaccines for Animals Revenue Market Share by Type (2021–2026)

Table 25. Global mRNA Vaccines for Animals Forecasted Market Size by Type (US$ Million), 2027–2032

Table 26. Global mRNA Vaccines for Animals Revenue Market Share by Type (2027–2032)

Table 27. Global mRNA Vaccines for Animals Market Size by Application (US$ Million), 2021–2026

Table 28. Global mRNA Vaccines for Animals Revenue Market Share by Application (2021–2026)

Table 29. Global mRNA Vaccines for Animals Forecasted Market Size by Application (US$ Million), 2027–2032

Table 30. Global mRNA Vaccines for Animals Revenue Market Share by Application (2027–2032)

Table 31. North America mRNA Vaccines for Animals Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 32. North America mRNA Vaccines for Animals Market Size by Country (US$ Million), 2021–2026

Table 33. North America mRNA Vaccines for Animals Market Size by Country (US$ Million), 2027–2032

Table 34. Europe mRNA Vaccines for Animals Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 35. Europe mRNA Vaccines for Animals Market Size by Country (US$ Million), 2021–2026

Table 36. Europe mRNA Vaccines for Animals Market Size by Country (US$ Million), 2027–2032

Table 37. Asia-Pacific mRNA Vaccines for Animals Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 38. Asia-Pacific mRNA Vaccines for Animals Market Size by Region (US$ Million), 2021–2026

Table 39. Asia-Pacific mRNA Vaccines for Animals Market Size by Region (US$ Million), 2027–2032

Table 40. Latin America mRNA Vaccines for Animals Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 41. Latin America mRNA Vaccines for Animals Market Size by Country (US$ Million), 2021–2026

Table 42. Latin America mRNA Vaccines for Animals Market Size by Country (US$ Million), 2027–2032

Table 43. Middle East & Africa mRNA Vaccines for Animals Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 44. Middle East & Africa mRNA Vaccines for Animals Market Size by Country (US$ Million), 2021–2026

Table 45. Middle East & Africa mRNA Vaccines for Animals Market Size by Country (US$ Million), 2027–2032

Table 46. Ceva Animal Health Company Details

Table 47. Ceva Animal Health Business Overview

Table 48. Ceva Animal Health mRNA Vaccines for Animals Product

Table 49. Ceva Animal Health Revenue in mRNA Vaccines for Animals Business (US$ Million), 2021–2026

Table 50. Ceva Animal Health Recent Development

Table 51. Merck Animal Health Company Details

Table 52. Merck Animal Health Business Overview

Table 53. Merck Animal Health mRNA Vaccines for Animals Product

Table 54. Merck Animal Health Revenue in mRNA Vaccines for Animals Business (US$ Million), 2021–2026

Table 55. Merck Animal Health Recent Development

Table 56. Areterna Company Details

Table 57. Areterna Business Overview

Table 58. Areterna mRNA Vaccines for Animals Product

Table 59. Areterna Revenue in mRNA Vaccines for Animals Business (US$ Million), 2021–2026

Table 60. Areterna Recent Development

Table 61. Bayer Company Details

Table 62. Bayer Business Overview

Table 63. Bayer mRNA Vaccines for Animals Product

Table 64. Bayer Revenue in mRNA Vaccines for Animals Business (US$ Million), 2021–2026

Table 65. Bayer Recent Development

Table 66. BioNTech Company Details

Table 67. BioNTech Business Overview

Table 68. BioNTech mRNA Vaccines for Animals Product

Table 69. BioNTech Revenue in mRNA Vaccines for Animals Business (US$ Million), 2021–2026

Table 70. BioNTech Recent Development

Table 71. Genvax Technologies Company Details

Table 72. Genvax Technologies Business Overview

Table 73. Genvax Technologies mRNA Vaccines for Animals Product

Table 74. Genvax Technologies Revenue in mRNA Vaccines for Animals Business (US$ Million), 2021–2026

Table 75. Genvax Technologies Recent Development

Table 76. BioVenic Company Details

Table 77. BioVenic Business Overview

Table 78. BioVenic mRNA Vaccines for Animals Product

Table 79. BioVenic Revenue in mRNA Vaccines for Animals Business (US$ Million), 2021–2026

Table 80. BioVenic Recent Development

Table 81. Moderna Company Details

Table 82. Moderna Business Overview

Table 83. Moderna mRNA Vaccines for Animals Product

Table 84. Moderna Revenue in mRNA Vaccines for Animals Business (US$ Million), 2021–2026

Table 85. Moderna Recent Development

Table 86. Ruipu Biotechnology Company Details

Table 87. Ruipu Biotechnology Business Overview

Table 88. Ruipu Biotechnology mRNA Vaccines for Animals Product

Table 89. Ruipu Biotechnology Revenue in mRNA Vaccines for Animals Business (US$ Million), 2021–2026

Table 90. Ruipu Biotechnology Recent Development

Table 91. Jinyu Bio-technology Company Details

Table 92. Jinyu Bio-technology Business Overview

Table 93. Jinyu Bio-technology mRNA Vaccines for Animals Product

Table 94. Jinyu Bio-technology Revenue in mRNA Vaccines for Animals Business (US$ Million), 2021–2026

Table 95. Jinyu Bio-technology Recent Development

Table 96. Shanghai Shen Lian Biomedical Company Details

Table 97. Shanghai Shen Lian Biomedical Business Overview

Table 98. Shanghai Shen Lian Biomedical mRNA Vaccines for Animals Product

Table 99. Shanghai Shen Lian Biomedical Revenue in mRNA Vaccines for Animals Business (US$ Million), 2021–2026

Table 100. Shanghai Shen Lian Biomedical Recent Development

Table 101. Suzhou Kerui Meide Biomedical Technology Company Details

Table 102. Suzhou Kerui Meide Biomedical Technology Business Overview

Table 103. Suzhou Kerui Meide Biomedical Technology mRNA Vaccines for Animals Product

Table 104. Suzhou Kerui Meide Biomedical Technology Revenue in mRNA Vaccines for Animals Business (US$ Million), 2021–2026

Table 105. Suzhou Kerui Meide Biomedical Technology Recent Development

Table 106. Shanghai Rnacure Biopharma Company Details

Table 107. Shanghai Rnacure Biopharma Business Overview

Table 108. Shanghai Rnacure Biopharma mRNA Vaccines for Animals Product

Table 109. Shanghai Rnacure Biopharma Revenue in mRNA Vaccines for Animals Business (US$ Million), 2021–2026

Table 110. Shanghai Rnacure Biopharma Recent Development

Table 111. Research Programs/Design for This Report

Table 112. Key Data Information from Secondary Sources

Table 113. Key Data Information from Primary Sources

Table 114. Authors List of This Report

List of Figures

Figure 1. mRNA Vaccines for Animals Picture

Figure 2. Global mRNA Vaccines for Animals Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global mRNA Vaccines for Animals Market Share by Type: 2025 vs 2032

Figure 4. Non-replicating mRNA vaccines Features

Figure 5. Self-replicating mRNA vaccines Features

Figure 6. Global mRNA Vaccines for Animals Market Size by Application (US$ Million), 2021–2032

Figure 7. Global mRNA Vaccines for Animals Market Share by Application: 2025 vs 2032

Figure 8. Pigs Case Studies

Figure 9. Poultry Case Studies

Figure 10. Companion Animals Case Studies

Figure 11. Ruminants Case Studies

Figure 12. mRNA Vaccines for Animals Report Years Considered

Figure 13. Global mRNA Vaccines for Animals Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 14. Global mRNA Vaccines for Animals Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 15. Global mRNA Vaccines for Animals Market Share by Region: 2025 vs 2032

Figure 16. Global mRNA Vaccines for Animals Market Share by Players in 2025

Figure 17. Global mRNA Vaccines for Animals Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 18. The Top 10 and 5 Players Market Share by mRNA Vaccines for Animals Revenue in 2025

Figure 19. North America mRNA Vaccines for Animals Market Size YoY Growth (US$ Million), 2021–2032

Figure 20. North America mRNA Vaccines for Animals Market Share by Country (2021–2032)

Figure 21. United States mRNA Vaccines for Animals Market Size YoY Growth (US$ Million), 2021–2032

Figure 22. Canada mRNA Vaccines for Animals Market Size YoY Growth (US$ Million), 2021–2032

Figure 23. Europe mRNA Vaccines for Animals Market Size YoY Growth (US$ Million), 2021–2032

Figure 24. Europe mRNA Vaccines for Animals Market Share by Country (2021–2032)

Figure 25. Germany mRNA Vaccines for Animals Market Size YoY Growth (US$ Million), 2021–2032

Figure 26. France mRNA Vaccines for Animals Market Size YoY Growth (US$ Million), 2021–2032

Figure 27. U.K. mRNA Vaccines for Animals Market Size YoY Growth (US$ Million), 2021–2032

Figure 28. Italy mRNA Vaccines for Animals Market Size YoY Growth (US$ Million), 2021–2032

Figure 29. Russia mRNA Vaccines for Animals Market Size YoY Growth (US$ Million), 2021–2032

Figure 30. Ireland mRNA Vaccines for Animals Market Size YoY Growth (US$ Million), 2021–2032

Figure 31. Asia-Pacific mRNA Vaccines for Animals Market Size YoY Growth (US$ Million), 2021–2032

Figure 32. Asia-Pacific mRNA Vaccines for Animals Market Share by Region (2021–2032)

Figure 33. China mRNA Vaccines for Animals Market Size YoY Growth (US$ Million), 2021–2032

Figure 34. Japan mRNA Vaccines for Animals Market Size YoY Growth (US$ Million), 2021–2032

Figure 35. South Korea mRNA Vaccines for Animals Market Size YoY Growth (US$ Million), 2021–2032

Figure 36. Southeast Asia mRNA Vaccines for Animals Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. India mRNA Vaccines for Animals Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. Australia & New Zealand mRNA Vaccines for Animals Market Size YoY Growth (US$ Million), 2021–2032

Figure 39. Latin America mRNA Vaccines for Animals Market Size YoY Growth (US$ Million), 2021–2032

Figure 40. Latin America mRNA Vaccines for Animals Market Share by Country (2021–2032)

Figure 41. Mexico mRNA Vaccines for Animals Market Size YoY Growth (US$ Million), 2021–2032

Figure 42. Brazil mRNA Vaccines for Animals Market Size YoY Growth (US$ Million), 2021–2032

Figure 43. Middle East & Africa mRNA Vaccines for Animals Market Size YoY Growth (US$ Million), 2021–2032

Figure 44. Middle East & Africa mRNA Vaccines for Animals Market Share by Country (2021–2032)

Figure 45. Israel mRNA Vaccines for Animals Market Size YoY Growth (US$ Million), 2021–2032

Figure 46. Saudi Arabia mRNA Vaccines for Animals Market Size YoY Growth (US$ Million), 2021–2032

Figure 47. UAE mRNA Vaccines for Animals Market Size YoY Growth (US$ Million), 2021–2032

Figure 48. Ceva Animal Health Revenue Growth Rate in mRNA Vaccines for Animals Business (2021–2026)

Figure 49. Merck Animal Health Revenue Growth Rate in mRNA Vaccines for Animals Business (2021–2026)

Figure 50. Areterna Revenue Growth Rate in mRNA Vaccines for Animals Business (2021–2026)

Figure 51. Bayer Revenue Growth Rate in mRNA Vaccines for Animals Business (2021–2026)

Figure 52. BioNTech Revenue Growth Rate in mRNA Vaccines for Animals Business (2021–2026)

Figure 53. Genvax Technologies Revenue Growth Rate in mRNA Vaccines for Animals Business (2021–2026)

Figure 54. BioVenic Revenue Growth Rate in mRNA Vaccines for Animals Business (2021–2026)

Figure 55. Moderna Revenue Growth Rate in mRNA Vaccines for Animals Business (2021–2026)

Figure 56. Ruipu Biotechnology Revenue Growth Rate in mRNA Vaccines for Animals Business (2021–2026)

Figure 57. Jinyu Bio-technology Revenue Growth Rate in mRNA Vaccines for Animals Business (2021–2026)

Figure 58. Shanghai Shen Lian Biomedical Revenue Growth Rate in mRNA Vaccines for Animals Business (2021–2026)

Figure 59. Suzhou Kerui Meide Biomedical Technology Revenue Growth Rate in mRNA Vaccines for Animals Business (2021–2026)

Figure 60. Shanghai Rnacure Biopharma Revenue Growth Rate in mRNA Vaccines for Animals Business (2021–2026)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Livestock mRNA Vaccines Market Research Report 2025

Messenger RNA Vaccines and Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Livestock Animal Vaccination Market Research Report 2025

Veterinary Vaccine Market

Global Livestock Vaccines Market Research Report 2025

Global mRNA Vaccines Therapeutics Market Research Report 2024

Global Livestock Animal Vaccines Market Research Report 2024

Global Veterinary Biological Vaccines Market Research Report 2025

Global mRNA Vaccine And Therapeutics Market Insights Forecast to 2030

Global Veterinary Vaccination Market Research Report 2025

Global mRNA Therapy Market Research Report 2024

mRNA Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Farm Animal Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Vaccines for Livestock Farming Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

mRNA Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Non Replicating mRNA Vaccine Market Research Report 2025

Global Personalized mRNA Cancer Vaccine Therapy Market Research Report 2025

Global Synthetic Peptide Vaccines for Veterinary Use Market Research Report 2025

Global mRNA Cancer Vaccines and Therapeutics Market Insights Forecast to 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions